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INTRODUCTION
Estrogen plays an important role in the function of
the urogenital tissue in adults, in which receptors for
estrogen and progesterone are found in the tissues of
the vagina, urethra, urinary bladder and the muscles
of the pelvic floor. Post menopausal estrogen defi-
ciency may cause atrophic changes of the urogenital
tract and cause symptoms of vaginal atrophy, such as,
dyspareunia, itching, rawness, and feelings of dry-
ness. Changes also are found in the urinary tract with
symptoms of frequency, urgency, nocturia, inconti-
nence, and recurrent infections.1,2
Estrogen deficiency causes atrophy of connective
tissues and epithellium of the urogenital tract includ-
ing the vaginal mucousa. Estrogen receptor α and β
distribution along the urogenital tract are found on
the vaginal side walls and uterosacral ligaments in the
premenopausal women, but are not seen in the post-
menopausal women. Estrogen influences the synthesis
and metabolism of collagen in the lower genital tract.
Atrophic vaginitis is a term used to explain a condi-
tion of inflammation of the vagina due to decreased
estrogen that causes vaginal epithelial atrophy, in
which all of the vaginal epithelial layers are absent,
except for the basal cell layer. The tissue that under-
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Objective: To find out atrophic vaginitis pattern in postmeno-
pausal women based on clinical appearance and vaginal cytology.
Method: Descriptive retrospective study with hypothesis cohort
to find out clinical appearance and vaginal cytology of atrophic
vaginitis based on distribution of estrogen effect (maturation va-
lue/total maturation index) in post menopausal women in outpatient
clinic of tertiary hospital in Manado, North Sulawesi.
Result: There were 50 subjects met the inclusion criteria. Most
of them are 55 to 59 years old, with length of menopausal period 6
to 20 years, and onset of menopause in 45 to 49 years old. Cytology
study showed that atrophic vaginitis present in 66% patients. Clini-
cal symptoms are ranging from vaginal dryness (10%), vaginal dis-
charge (6%), and dyspareunia (20%). From clinical appearance we
found 44% women had atrophic vaginitis based on vaginal secre-
tion, 42% based on macroscopic surface/integrity of vaginal epithe-
lium, 54% based on vaginal rugae and elasticity, and 42% based on
vaginal color. However, 80% of all participants showed vaginal pH
more than 7 and most of them categorized as having atrophic vagi-
nitis.
Conclusion: By using clinical appearance, we found 42% to
54% of menopausal women had atrophic vaginitis, while cytology
study confirmed 66% having it.
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Abstrak
Tujuan: Untuk mengetahui gambaran Vaginitis Atrofi pada pe-
rempuan pascamenopause berdasarkan tampilan klinis dan sito-
logi vagina.
Metode: Merupakan penelitian deskriptif-retrospektif dengan
hypothesis cohort untuk mendapatkan tampilan klinis dan sitologi
vagina dari vaginitis atrofi berdasarkan distribusi efek estrogen
(Maturation Value/Total Indeks Maturasi) pada perempuan pasca-
menopause yang kontrol di Poliklinik Rumah Sakit di Manado, Su-
lawesi Utara.
Hasil: Didapatkan 50 sampel sesuai kriteria inklusi, terbanyak
usia 55 - 59 tahun (42%), lama menopause antara 6 - 20 tahun
(50%), onset menopause antara 45 - 49 tahun (46%), Secara si-
tologi, prosentase vaginitis atrofi sebanyak 66%, lebih tinggi dari
hipotesis penelitian (p < 0,0001). Keluhan pada vaginitis atrofi
yaitu rasa kering sebanyak 10%, keputihan 6% dan dispareunia
20%. Berdasarkan tampilan klinis didapatkan sekresi vagina nor-
mal sebanyak 56%, sedangkan 44% atrofi. Integritas epitel vagina
atrofi 46%. Berdasarkan ketebalan epitel vagina 42% atrofi. Warna
vagina normal 58% sedangkan 42% atrofi. Delapan puluh persen
sampel mempunyai pH vagina basa, dengan kejadian vaginitis
atrofi 82%, sedangkan pada pH vagina asam tidak ditemukan ke-
jadian vaginitis atrofi. Didapatkan kejadian infeksi pada vaginitis
atrofi sebesar 21%.
Kesimpulan: Dengan menggunakan tampilan klinis, kami me-
nemukan 42% sampai 54% dari wanita menopause telah atrophic
vaginitis, sementara studi sitologi dikonfirmasi 66% memilikinya.
[Maj Obstet Ginekol Indones 2010; 34-2: 92-6]
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goes atrophy is the vaginal mucosa, cervix, endocer-
vix, endometrium, and uroepithellium. Along with the
decrease in estrogen production, the vaginal mucosa
becomes thin, vaginal secretions reduced, in a way
that gives way to symptoms of sexual dysfunction and
discomfort of the vagina and vulva, in which these
symptoms in the end will result in disturbance of daily
life of the postmenopausal women.
Post menopausal women with atrophic vaginitis are
also susceptible to vaginal infections. Susceptibility
to infection, in addition to be caused by the thinning
of the vaginal epithelium, is also due to an increase
in vaginal pH and alterations of the normal vaginal
flora in such a way that its function as a barrier to
infections by microorganism becomes less effective.
Alteration of the normal vaginal flora cause colonili-
zation by gram negative bacilli that may cause symp-
toms of local imitation of the vaginal mucosa.1,3
Brizzolara et al.4 in the United States found that a
vaginal pH > 4 is associated with the increase in num-
ber of parabasal cells (≥ 20%) in smears from the
proximal to mid vagina. According cytologic defini-
tions, in atrophic vaginitis there is an increase in pa-
rabasal and intermediate cells in comparison with su-
perficial cells that illustrates low estrogen effect.5-8
Nuryanto K.H5 reported the incidence of atrophic
vaginitis of 63.2%. Atrophic vaginitis are found clini-
cally found in around 75 - 85% of postmenopausal
women, even so only around 40% of postmenopausal
women complain symptoms of atrophic vaginitis.2,3
METHOD
This is a descriptive study. The sample population are
post menopausal women, who has not received any
estrogen or hormone replacement therapy, aged 46 -
65 years old that comes regularly to the gynecology
clinic of the Prof. Dr. R. D. Kandou Hospital, Manado
- Department of Obstetrics and Gynecology, Faculty
of Medicine Sam Ratulangi University and the Obs-
tetrics and Gynecology clinic of the Robert Wolter
Monginsidi Hospital, Manado. Sample collection was
conducted from December 2008 to January 2009.
History taking of the study participants were con-
ducted by the authors with a guide to the presence of
atrophic vaginitis, which covers the presence of a
feeling of dryness, friction on the perineum during
sexual intercourse, a feeling of fullness, pressure or
swelling of the vagina, pain or irritation of the peri-
neum when in contact with clothing, pain during sex-
ual intercourse and presence of vaginal secretion.
Clinical vaginal examinations elucidate vaginal secre-
tions, vaginal epithelial cell integrity, vaginal surface
thickness, color and texture of the vaginal surface.
Vaginal examination were conducted using a graves
speculum, and when required was lubricated with wa-
ter to aid speculum insertion.
Examination of the vaginal pH were conducted us-
ing a pH dipstick indicator by applying it to the fluid
found on the surface of the vaginal wall or in cases
where secretion were not visible, the dipstick was ap-
plied to the vaginal wall for a duration of 1 minute.
Quantitative interpretation was done based on color
contrast parameters from pH indicator container. A
pH of 5 or less was considered acidic and a vaginal
pH of 7 or more was considered to be basic.
Vaginal smears were taken for evaluation of cell
maturity from the lateral wall of the one-third proxi-
mal vagina using blunt Ayre spatula and was then
smeared on an object glass that has already been la-
beled with the participants’ identity. The sample was
then immersed in 95% alcohol for approximately 30
minutes, then dried off using an air dryer, packed in
a safe container and was then sent to the cytology
laboratory of the Anatomic Pathology Department,
Faculty of Medicine UNSRAT. The smears were then
stained using papanicolau staining.
Evaluation of cell maturation was conducted by
counting the number of parabasal cells (PB), Interme-
diate cells (I), and superficial cells (S) and expressed
by the ratio PB: I: S. Evaluation of cell maturity are
done under the microscope by counting the number
of parabasal, intermediate, and superficial cells within
100 cells. The number of parabasal cells are then mul-
tiplied by 0, the number of intermediate cells are mul-
tiplied by 0.5 and the number of superficial cells mul-
tiplied by 1. From the sum of all three cell calcula-
tions, the value of cell maturity is acquired. A ma-
turity index/value between 0 - 49 reflects low estrogen
effect, a value of 50 - 64 shows intermediate estrogen
effect, and a maturation value of 65 - 100 shows high
estrogen effect.
Comparisons of parabasal, intermediate, and super-
ficial cells were conducted. If by microscopic evalu-
ation superficial cells are found fewer than 30% or
not at all, it would mean that the effect of estrogen
is low. Evaluation and quantification were conducted
by the author(s)/(research team), and were also con-
ducted by the cytopathologist for confirmation to in-
crease the objectivity of the results. In the event that
the maturation index is found to show low estrogen
effect, the samples were considered as atrophic vagi-
nitis and would then be analyzed further and treated.
In this study we conducted data collection, evalu-
ation, and tabulation and presented in the form of ta-
bles, then further analyzed descriptively by applying
the Z test for hypothesis testing of the study.
RESULT
A study was conducted on 49 post menopausal wo-
men that came to the Obstetrics and Gynecology
clinic of Prof. Dr. R.D. Kandou General Hospital and
Robert W. Monginsidi Hospital, Manado between De-
cember 2008 to January 2009 and 50 samples of post-
menopausal women fulfilled the study inclusion cri-
teria.
In accordance with cytology definition, in atrophic
vaginitis, the number of parabasal and intermediate
cells will increase in comparison with the number of
superficial cells, which illustrates a low estrogen ef-
fect.
Atrophic vaginitis are found in 33 (66%) of the
study participants. This result was higher than was
stated in the study hypothesis of > 40% of postme-
nopausal women experiencing atrophic vaginitis (p <
0.0001).
The occurrence of infection were also found along
with atrophic vaginitis in 7 participants, and as much
as 26 participants without infection among the total
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study participants. From this entire study we found a
total of 15 participants having infections, specifically:
N Gardnerella Vaginalis : 4 participants
N Coccen vaginalis : 7 participants
N Trichomonas vaginalis : 1 participants
N HPV infection : 2 participants
Table 1. Distribution of estrogen effect on vaginal cytology in
postmenopausal women
Estrogen effect Infection (+) Infection (-) N %
Low  7 26 33  66
Moderate  4  1  5  10
High  4  8 12  24
Total 15 35 50 100
Information:
Atrophy vaginitis (+) : low estrogen effect
Atrophy vaginitis (-) : moderate or high estrogen effect
Five (10%) participants complains about dryness
feeling, and there are no participants complaining
about vaginal compresion and iritation based on
anamnesis, however there are only three (6%) partici-
pants complaining leukorhea and 10 (20%) partici-
pants complaining about dispareunia (Table 2).
Table 2. Distribution based of vaginal symptoms
Symptoms Atrophy va-
ginitis (+)
Atrophy va-
ginitis (-)
N %
Dryness
(+)  2  3  5  10
(-) 31 14 45  90
Compression
(+)  0  0  0   0
(-)  0 50 50 100
Iritation
(+)  8  2 10  20
(-) 19 21 40  80
Dispareunia
(+)  3  0  3   6
(-) 30 17 47  94
Leukorhea
(+)  0  0  0   0
(-)  0 50 50 100
N Vaginal secretions
Classification of vaginal secrete are normal (posi-
tive secretes) and atrophy (no secretes or need lu-
brication for painless speculum examination).
From vaginal secretions, there are 28 (56%) par-
ticipants have normal secretes and 22 (44%) par-
ticipants have atrophy (Table 3).
N Macroscopic surface/integrity of vaginal epithelium
The classification of the vaginal epithelium are
normal (pink vaginal wall, humid and un-shinny)
and atrophy (pale vaginal wall, dry, shiny and there
are no petechiae on vaginal surface or bleed easily
on vaginal examination). Normal vagina epithelium
integrity found in 27 (54%) participants, however
there are 21 (42%) were atrophy (Table 3).
N Rugae/vaginal wall elasticity
The classification of vaginal wall elasticity are nor-
mal (elastic vaginal wall and proper number of ru-
gae) and atrophy (less number of rugae or very
smooth vaginal wall with only upper third elasticity
of vaginal wall or there is no elasticity at all). we
found 29 (58%) participants have normal thickness
of vaginal epithelium and 21 (42%) participants are
atrophy (Table 3).
N Vaginal colour
The classification of the vaginal colour are normal
(pink vaginal wall) and atrophy (pink to pale white
colour vaginal wall). We found 29 (58%) partici-
pants have normal vaginal wall colour, however we
found atrophy on 21 (42%) participants (Table 3).
Table 3. Distribution of frequency based on vaginal examination
Examination Normal Atrophy
Vaginal secretion 28 (56%) 22 (44%)
Vaginal wall epithe-
lium integrity
27 (54%) 23 (46%)
Vaginal wall surface 29 (58%) 21 (42%)
Vaginal colour 29 (58%) 21 (42%)
From table 4, we got base vaginal pH on 40 (80%)
participants and the incidence of atrophy vaginitis is
33 (82%) participants. Thus, acid vaginal pH on 10
(20%) participants and there is no atrophy vaginitis.
Table 4. Frequency distribution on vaginal pH
Vaginal pH Atrophy va-
ginitis (+)
Atrophy va-
ginitis (-)
N %
Acid (pH ≤ 7)  0 10 10  20
Base (pH ≥ 7) 33  7 40  80
Total 33 17 50 100
DISCUSSION
In this research, from 59 women screened for post
menopause, we got 50 women who include in the cri-
teria for this research. The research based on the cha-
racteristic (age, duration of menopause, onset of me-
nopause, education status, occupation, obstetric his-
tory taking, coital history taking), vaginal complains,
vaginal examination, vaginal pH examination and va-
ginal cytology examination.
The highest range of age in post menopausal wo-
men in this research is between 55 - 59 years old for
21 (42%) participants. Followed by 50 - 54 years old
for 16 (32%) participants, > 59 years old for 9 (18%)
participants and 45 - 49 years old for 4 (8%) partici-
pants. The youngest participant in this research is on
age 45 years old and the oldest is on 65 years old.
Based on other cross sectional research, they found
mean of age of menopausal women between 44 - 56
years old. They report only on cigarete smoking par-
ticipants have an early menopausal incidence with de-
viation of 1.5 years more early. A corelation between
mother and female daughter have a high incidence of
early menopause (< 40 years), but only in sporadic
manner.9
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Based on the duration of post menopause, the long-
est duration is 6 - 20 years for 25 (50%) participants,
followed by 4 - 5 years for 13 (26%) participants,
one year for 7 (14%) participants and 2 - 3 years for
5 (10%) participants. The shortest duration of post
menopause is one year and the longest is 20 years.
This time of duration wil be correlated to symptoms
and clinical findings.
We predict in four to five year of menopause, there
will be one of women not using estrogen replacement
therapy experiencing an atrophy. The symptoms of it
are dryness feeling, dispareunia and recurent vaginal
infection. But, these symptoms are reversible with the
therapy of estrogen. In research with placebo control,
they found estrogen administration will reduce the
symptoms of vaginal atrophy i.e vaginal dryness, which
have the effect on increasing libido and sexual func-
tion because it has the effect on vaginal lubrication.10
In this research, the most frequent complains dis-
pareunia for 10 participants (20%), followed by leu-
korhea for 3 participants (6%) and dryness feeling for
5 participants (10%). However feeling of compression
and iritation have not been elucidated.
Although menopause is a nature process, actually
it can produce many symptoms in daily life. A symp-
toms like vaginal atrophy count for 40% of post
menopausal women, but majority of them does not
seek for therapy.
Clinical diagnosis of vaginal atrophy was estab-
lished based on symptom of reduced vaginal dis-
charge to 22 people (44%), the reduced integrity of
the vaginal epithelium by 23 women (46%), reduced
thickness of the vaginal epithelium and pale vaginal
color each consisted of 21 women (42%).
Based on clinical examination, vaginal pH is a
more objective examination compared to others.
Where from overall clinical variables, except the pH
of the vagina, athropical vaginitis did not reach half
of the number of study participants. But when related
with vaginal pH and the effects of estrogen on the
results of cytology, the examination should be more
accurate where the occurrence of atrophical vaginitis
was found in more than half of study participants.
This is coherent with the theory results are consistent
with the theory that atrophica vaginitis 40% in post-
menopausal women.
According to the examination of vaginal hormonal
cytology, it was stated found that low estrogen effect
is occuringthis 66% samples, indicating the occurren-
ce of atrophical vaginitis in postmenopausal women
examined. Meanwhile the distribution of the modera-
te-estrogen effects is 5 people (10%) and distribution
of the high-estrogen effects as many as was 24% of
50 samples, indicating the absence of atrophical vagi-
nitis among women in the postmenopausal women ex-
amined. Comparison between clinical appereance and
cytology study reveals that cytology study give a bet-
ter sensitifity diagnois athropic vaginitis. Through the
vaginal cytology examination, find Gardnerella vagi-
nalis, Coccen vaginalis and HPV Trichomonas vagi-
nalis infection manifestations.
Bacterial vaginosis (BV) is a polimicrobial disor-
der, characterized by the increase of vaginal pH above
4.5, reduction or absence of Lactobasillus coloniza-
tion and the growth of certain anaerobic bacteria. Few
literatures evaluated the prevalence of BV in meno-
pausal women there was not enough data describing
the effects of hormone replacement therapy on the
prevalence of BV. Sabina, et al. assessing BV preva-
lence in women over 40 years with Gram stain vagi-
nal smears of BV to italiana-caucásias women, They
found up to 5.4% incidence in the use of HRT and
6% obtained HRT-free positive results with VB.
According to Nuryanto’s research, that dryness
complaints of 16.6% was found in women who expe-
rience atrophical vaginitis while Silalahi, et al. found
3.6% of menopausal women with symptoms of vagi-
nal dryness who consulted to physician. Ziegler, et
al. found more than 43% of vaginal dryness com-
plaints in women above 60 years. There are 17% vagi-
nal complaints dryness in menopausal women using
infant detergent formula.
Hormonal vaginal cytology relationship with the
distribution of the incidence of atrophical vaginitis in
postmenopausal women without dyspareunia com-
plaints showed atrophical vaginitis incidence was 19
people (59%) of 32 samples compared to the distri-
bution of dyspareunia complaints in accordance with
the incidence of atrophical vaginitis that showed 14
people (78%) of 18 samples.
Dyspareunea complaint and other sexual dysfunc-
tional patterns usually occur in postmenopausal wo-
men. According to Laumann, et al. (1999) in a re-
search study on the prevalence of sexual dysfunction
in postmenopausal women. It was found 25% of
women complained dyspareunia in which pain during
sexual activity is correlated with the presence of sex-
ual problems including decreased of libido, loss of
sexual desire and anorgasmia. This may be related to
the reduction of the number of male sexual partners
with advanced age in a population. Menopausal vagi-
nal changes in women can cause decreased sexual de-
sire. This inconveniency is caused by the loss of vagi-
nal lubrication effect that causes the underlying dys-
pareunia.
Based on the relationship between cytological hor-
monal vaginitis with the distribution of the atrophical
vaginal incidence in postmenopausal women without
leukorrheae complaint showed atrophy vaginitis inci-
dence of as many as 30 people (64%) of 47 samples
compared to the distribution according to the leukor-
rheae complaint showed atrophical vaginitis incident
of 3 (100%) from 3 samples. In postmenopausal wo-
men, there was a decrease of Lactobacilus as a normal
flora colonization, increased vaginal pH and coccen-
gram-positive bacterial levels and coliform; prevalence
of Bacterial Vaginosis (BV) is significantly lower
compared to the reproductive age and perimenopausal
women. Decrease of Lactobacilus colonization is the
main cause of ecological development to become an-
aerobic vagina, which provide a complaint of inflam-
mation and infection of the vaginal ecosystem damag-
ing impacts on the complaints such as leukorrheae.
Distribution of atrophical vaginitis incidence based
on clinical study in postmenopausal women showed
that in the group of vaginal pH with the results of the
alkaline pH as many as 33 people (82%) of 40 sam-
ples while in a group with acidic pH found no cases
of atrophical vaginitis. In the study sample showed
the lowest vaginal pH is 7, while the highest is 12.
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Because this study is a diagnostic test thus there
are 50 samples of only 33 in cytologic samples ex-
pressed as atrophic vaginitis. Since vaginal pH result
is the most significant finding in the clinical exami-
nation thus we can get a significant relationship be-
tween vaginal pH with atrophical vaginitis.
Alkaline pH condition causes vaginal ambient less
susceptible to the Lactobacillus and vulnerable to pa-
thogenic bacterial of urogenital and fecal tract infec-
tions. Vaginal pH 6-7, the absence of aerobic pathoge-
nic bacterial becomes marker of estradiol status on
most of menopausal women.
Gebhart, et al. found atrophical vaginitis in 50%
of 75 post menopausal women samples.
On the other hand, Elghany found the incidence of
atrophy vaginitis was 15% in premenopausal women
and 40% in postmenopausal women. Nuryanto K.H
found 63.2% atrophy vaginitis from 38 samples stu-
died.
Research in Manado, North of Sulawesi found the
incidence of atrophy vaginitis was 33 subject (66%)
from vaginal cytologic examination in 50 postmeno-
pausal women. The incidence of atrophy vaginitis in
postmenopausal women here was higher than the re-
sults of study conducted by other researchers.
CONCLUSION
Incidence of atrophy vaginitis in this study was 66%
obtained from vaginal cytologic examination, based
on distribution of low estrogen effect (Maturation va-
lue/Total Maturation index between 0 - 49). The most
common complain in postmenopausal women who
participated in this study was dyspareunia (20%)
where 6% had atrophy vaginitis.
In the vaginal pH examination, mostly vaginal pH
was alkaline where 80% had atrophy vaginitis.
Further study with larger samples is needed in or-
der to know the relationship between the other com-
plaints with clinical examination including vaginal pH
and vaginal cytology should be evaluated either clini-
cally or based on vaginal cytology, so that it could
be the basis of management guideline in postmeno-
pausal women.
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